Concepts (228)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Single-Cell Analysis | 13 | 2024 | 156 | 5.240 |
Why?
|
| NF-kappa B | 11 | 2025 | 469 | 4.440 |
Why?
|
| Microfluidics | 10 | 2023 | 54 | 3.260 |
Why?
|
| Microfluidic Analytical Techniques | 10 | 2020 | 46 | 2.440 |
Why?
|
| Cell Culture Techniques | 8 | 2020 | 194 | 2.360 |
Why?
|
| Signal Transduction | 14 | 2025 | 3403 | 2.250 |
Why?
|
| RNA, Messenger | 7 | 2024 | 2026 | 1.690 |
Why?
|
| Proteins | 3 | 2024 | 786 | 1.620 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2024 | 490 | 1.570 |
Why?
|
| Organoids | 2 | 2022 | 65 | 1.490 |
Why?
|
| Cell Communication | 2 | 2024 | 200 | 1.380 |
Why?
|
| Macrophages | 4 | 2025 | 582 | 1.290 |
Why?
|
| Cytokines | 6 | 2023 | 811 | 1.210 |
Why?
|
| Lab-On-A-Chip Devices | 5 | 2019 | 24 | 1.190 |
Why?
|
| Antiviral Agents | 6 | 2024 | 482 | 1.170 |
Why?
|
| Lipopolysaccharides | 4 | 2017 | 295 | 1.160 |
Why?
|
| Herpesvirus 1, Human | 4 | 2025 | 245 | 1.130 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2019 | 305 | 1.090 |
Why?
|
| High-Throughput Screening Assays | 2 | 2020 | 58 | 1.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 8 | 2021 | 700 | 0.910 |
Why?
|
| Fibroblasts | 3 | 2015 | 759 | 0.900 |
Why?
|
| Animals | 29 | 2025 | 27526 | 0.860 |
Why?
|
| Proteomics | 2 | 2024 | 232 | 0.860 |
Why?
|
| 3T3 Cells | 7 | 2021 | 97 | 0.810 |
Why?
|
| Cellular Microenvironment | 2 | 2019 | 29 | 0.800 |
Why?
|
| Biosensing Techniques | 1 | 2023 | 73 | 0.790 |
Why?
|
| Chromatin | 1 | 2025 | 403 | 0.790 |
Why?
|
| Mice | 19 | 2025 | 11851 | 0.780 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2022 | 206 | 0.770 |
Why?
|
| Formaldehyde | 1 | 2021 | 52 | 0.770 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2022 | 35 | 0.760 |
Why?
|
| Gene Expression Regulation | 7 | 2022 | 1983 | 0.750 |
Why?
|
| Cell Membrane | 1 | 2024 | 677 | 0.750 |
Why?
|
| Cell Tracking | 2 | 2018 | 14 | 0.740 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2020 | 78 | 0.720 |
Why?
|
| Polymers | 1 | 2021 | 196 | 0.700 |
Why?
|
| Bacteriological Techniques | 1 | 2020 | 39 | 0.700 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2020 | 76 | 0.680 |
Why?
|
| Proteome | 1 | 2021 | 135 | 0.680 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 241 | 0.680 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2017 | 91 | 0.670 |
Why?
|
| Transcription Factors | 3 | 2025 | 1665 | 0.650 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2018 | 14 | 0.640 |
Why?
|
| Neural Stem Cells | 1 | 2019 | 58 | 0.630 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 600 | 0.630 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2018 | 12 | 0.620 |
Why?
|
| Polymerase Chain Reaction | 2 | 2022 | 919 | 0.610 |
Why?
|
| Host-Pathogen Interactions | 2 | 2022 | 237 | 0.600 |
Why?
|
| Chemotaxis | 2 | 2016 | 73 | 0.570 |
Why?
|
| Lipopeptides | 1 | 2017 | 17 | 0.570 |
Why?
|
| Chemokine CCL19 | 1 | 2016 | 10 | 0.560 |
Why?
|
| Chemokine CCL21 | 1 | 2016 | 16 | 0.560 |
Why?
|
| Virus Replication | 6 | 2025 | 326 | 0.550 |
Why?
|
| Gene Expression Profiling | 5 | 2022 | 1452 | 0.540 |
Why?
|
| Basigin | 1 | 2016 | 5 | 0.530 |
Why?
|
| Transcriptome | 1 | 2021 | 661 | 0.530 |
Why?
|
| Bacteria | 1 | 2020 | 486 | 0.520 |
Why?
|
| Cells | 1 | 2016 | 32 | 0.520 |
Why?
|
| Salmonella typhimurium | 1 | 2015 | 33 | 0.510 |
Why?
|
| Paracrine Communication | 1 | 2015 | 32 | 0.490 |
Why?
|
| Transcription, Genetic | 2 | 2019 | 1158 | 0.460 |
Why?
|
| Allergy and Immunology | 1 | 2014 | 13 | 0.460 |
Why?
|
| Genome, Viral | 2 | 2025 | 82 | 0.460 |
Why?
|
| Systems Biology | 1 | 2014 | 44 | 0.450 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2020 | 520 | 0.430 |
Why?
|
| Dendritic Cells | 1 | 2016 | 451 | 0.420 |
Why?
|
| Cell Line | 7 | 2024 | 2495 | 0.420 |
Why?
|
| Autoimmunity | 1 | 2014 | 169 | 0.410 |
Why?
|
| Cell Differentiation | 1 | 2019 | 1533 | 0.410 |
Why?
|
| Gene Regulatory Networks | 1 | 2015 | 310 | 0.400 |
Why?
|
| NIH 3T3 Cells | 3 | 2019 | 110 | 0.400 |
Why?
|
| Humans | 27 | 2025 | 89924 | 0.380 |
Why?
|
| Cysteine Proteinase Inhibitors | 2 | 2021 | 53 | 0.380 |
Why?
|
| HEK293 Cells | 4 | 2025 | 646 | 0.370 |
Why?
|
| Herpes Simplex | 2 | 2024 | 203 | 0.360 |
Why?
|
| Time-Lapse Imaging | 3 | 2019 | 20 | 0.350 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 2331 | 0.330 |
Why?
|
| Coculture Techniques | 2 | 2023 | 176 | 0.330 |
Why?
|
| Mice, Inbred C57BL | 3 | 2025 | 3252 | 0.320 |
Why?
|
| Cells, Cultured | 4 | 2018 | 2887 | 0.300 |
Why?
|
| Automation | 2 | 2020 | 112 | 0.290 |
Why?
|
| A549 Cells | 3 | 2022 | 42 | 0.290 |
Why?
|
| Vero Cells | 3 | 2024 | 103 | 0.270 |
Why?
|
| Gene Expression Regulation, Viral | 3 | 2025 | 93 | 0.260 |
Why?
|
| Cell Nucleus | 3 | 2023 | 602 | 0.260 |
Why?
|
| Benzamides | 2 | 2023 | 234 | 0.250 |
Why?
|
| Piperidines | 2 | 2023 | 163 | 0.240 |
Why?
|
| Coronavirus OC43, Human | 2 | 2021 | 7 | 0.240 |
Why?
|
| Zygote | 1 | 2025 | 41 | 0.240 |
Why?
|
| Drug Repositioning | 1 | 2024 | 23 | 0.240 |
Why?
|
| Drug Discovery | 2 | 2022 | 107 | 0.240 |
Why?
|
| Computational Biology | 2 | 2021 | 551 | 0.230 |
Why?
|
| Thiazoles | 2 | 2023 | 127 | 0.230 |
Why?
|
| Microscopy, Fluorescence | 3 | 2017 | 434 | 0.230 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2021 | 885 | 0.230 |
Why?
|
| Pyridines | 2 | 2023 | 300 | 0.230 |
Why?
|
| Acyclovir | 1 | 2024 | 108 | 0.230 |
Why?
|
| NF-KappaB Inhibitor alpha | 2 | 2021 | 42 | 0.210 |
Why?
|
| Substrate Specificity | 2 | 2016 | 352 | 0.210 |
Why?
|
| DNA, Viral | 1 | 2023 | 263 | 0.210 |
Why?
|
| Middle East Respiratory Syndrome Coronavirus | 1 | 2022 | 11 | 0.210 |
Why?
|
| Stochastic Processes | 2 | 2015 | 77 | 0.210 |
Why?
|
| Protein Interaction Mapping | 1 | 2022 | 81 | 0.200 |
Why?
|
| Cannabidiol | 1 | 2022 | 8 | 0.200 |
Why?
|
| Cloud Computing | 1 | 2021 | 13 | 0.190 |
Why?
|
| Oligonucleotides | 1 | 2022 | 92 | 0.190 |
Why?
|
| Sepsis | 1 | 2025 | 329 | 0.180 |
Why?
|
| Homeodomain Proteins | 1 | 2025 | 559 | 0.180 |
Why?
|
| Microtechnology | 1 | 2020 | 3 | 0.180 |
Why?
|
| Saliva | 1 | 2021 | 124 | 0.180 |
Why?
|
| Mass Spectrometry | 1 | 2021 | 194 | 0.180 |
Why?
|
| Neoplasm Metastasis | 1 | 2024 | 1066 | 0.170 |
Why?
|
| User-Computer Interface | 1 | 2021 | 187 | 0.170 |
Why?
|
| Mutation | 2 | 2023 | 4165 | 0.170 |
Why?
|
| Fluorescein-5-isothiocyanate | 2 | 2016 | 26 | 0.170 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 2767 | 0.170 |
Why?
|
| Limit of Detection | 1 | 2019 | 20 | 0.170 |
Why?
|
| Flow Cytometry | 1 | 2021 | 690 | 0.170 |
Why?
|
| Intravital Microscopy | 1 | 2019 | 11 | 0.170 |
Why?
|
| Cell Line, Tumor | 2 | 2024 | 2587 | 0.160 |
Why?
|
| DNA, Bacterial | 1 | 2020 | 244 | 0.160 |
Why?
|
| Cell Survival | 2 | 2013 | 983 | 0.160 |
Why?
|
| Jurkat Cells | 1 | 2019 | 77 | 0.160 |
Why?
|
| Colon | 1 | 2022 | 521 | 0.160 |
Why?
|
| Shock, Septic | 1 | 2020 | 105 | 0.160 |
Why?
|
| Inflammation | 1 | 2025 | 981 | 0.160 |
Why?
|
| Neoplasms | 1 | 2014 | 3065 | 0.160 |
Why?
|
| Gene Dosage | 1 | 2019 | 210 | 0.160 |
Why?
|
| Tissue Array Analysis | 1 | 2018 | 126 | 0.150 |
Why?
|
| Proof of Concept Study | 1 | 2018 | 48 | 0.150 |
Why?
|
| Immunity, Innate | 1 | 2022 | 434 | 0.150 |
Why?
|
| Computer Simulation | 1 | 2022 | 1102 | 0.150 |
Why?
|
| Genes, Reporter | 1 | 2018 | 274 | 0.150 |
Why?
|
| Immunoassay | 1 | 2017 | 91 | 0.140 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2017 | 387 | 0.140 |
Why?
|
| Green Fluorescent Proteins | 1 | 2018 | 309 | 0.140 |
Why?
|
| TNF Receptor-Associated Factor 6 | 1 | 2017 | 6 | 0.140 |
Why?
|
| beta Catenin | 1 | 2019 | 267 | 0.140 |
Why?
|
| RNA | 1 | 2021 | 583 | 0.140 |
Why?
|
| Cell Cycle | 1 | 2019 | 508 | 0.140 |
Why?
|
| Cell Adhesion | 1 | 2018 | 426 | 0.140 |
Why?
|
| Photobleaching | 1 | 2016 | 8 | 0.140 |
Why?
|
| Immobilized Proteins | 1 | 2016 | 14 | 0.140 |
Why?
|
| Models, Biological | 2 | 2016 | 1765 | 0.130 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2017 | 202 | 0.130 |
Why?
|
| Clone Cells | 1 | 2016 | 214 | 0.130 |
Why?
|
| Cell Movement | 2 | 2016 | 786 | 0.130 |
Why?
|
| Cell Separation | 1 | 2016 | 199 | 0.130 |
Why?
|
| Bone Marrow Cells | 1 | 2016 | 262 | 0.130 |
Why?
|
| Bacterial Infections | 1 | 2017 | 184 | 0.120 |
Why?
|
| Acoustics | 1 | 2015 | 51 | 0.120 |
Why?
|
| Spectrum Analysis | 1 | 2015 | 119 | 0.120 |
Why?
|
| Pancreatic Neoplasms | 1 | 2020 | 684 | 0.120 |
Why?
|
| Portraits as Topic | 1 | 2014 | 6 | 0.120 |
Why?
|
| Time Factors | 2 | 2015 | 5357 | 0.110 |
Why?
|
| Transcription Factor RelA | 1 | 2013 | 50 | 0.110 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2013 | 66 | 0.110 |
Why?
|
| Diffusion | 1 | 2013 | 93 | 0.110 |
Why?
|
| Models, Theoretical | 1 | 2015 | 493 | 0.100 |
Why?
|
| MicroRNAs | 1 | 2017 | 556 | 0.100 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2015 | 450 | 0.100 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2022 | 86 | 0.100 |
Why?
|
| Interferons | 2 | 2022 | 127 | 0.100 |
Why?
|
| Endoribonucleases | 2 | 2022 | 94 | 0.100 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2021 | 151 | 0.090 |
Why?
|
| Viral Load | 2 | 2021 | 145 | 0.090 |
Why?
|
| Breast Neoplasms | 1 | 2024 | 3021 | 0.090 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2010 | 78 | 0.090 |
Why?
|
| Mice, Knockout | 1 | 2015 | 2015 | 0.090 |
Why?
|
| Software | 1 | 2014 | 669 | 0.090 |
Why?
|
| Equipment Design | 2 | 2017 | 422 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 1929 | 0.070 |
Why?
|
| Merkel cell polyomavirus | 1 | 2025 | 2 | 0.060 |
Why?
|
| Herpesviridae | 1 | 2025 | 15 | 0.060 |
Why?
|
| Drug Resistance, Viral | 1 | 2024 | 48 | 0.060 |
Why?
|
| Serial Passage | 1 | 2023 | 3 | 0.060 |
Why?
|
| Drug Synergism | 1 | 2024 | 307 | 0.060 |
Why?
|
| Keratinocytes | 1 | 2024 | 146 | 0.060 |
Why?
|
| Eukaryotic Cells | 1 | 2023 | 44 | 0.060 |
Why?
|
| Protease Inhibitors | 1 | 2023 | 72 | 0.050 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2022 | 17 | 0.050 |
Why?
|
| Inositol | 1 | 2022 | 16 | 0.050 |
Why?
|
| Ribonucleases | 1 | 2022 | 93 | 0.050 |
Why?
|
| Ligands | 1 | 2023 | 447 | 0.050 |
Why?
|
| Virus Internalization | 1 | 2022 | 40 | 0.050 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2021 | 64 | 0.050 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2021 | 38 | 0.050 |
Why?
|
| Catalytic Domain | 1 | 2021 | 156 | 0.050 |
Why?
|
| Viral Proteins | 1 | 2022 | 302 | 0.050 |
Why?
|
| Drug Design | 1 | 2021 | 126 | 0.050 |
Why?
|
| Bacterial Load | 1 | 2020 | 19 | 0.040 |
Why?
|
| beta-Lactam Resistance | 1 | 2020 | 11 | 0.040 |
Why?
|
| Gram-Negative Bacteria | 1 | 2020 | 35 | 0.040 |
Why?
|
| Gram-Positive Bacteria | 1 | 2020 | 18 | 0.040 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2020 | 35 | 0.040 |
Why?
|
| Decision Trees | 1 | 2020 | 60 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2021 | 283 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2021 | 318 | 0.040 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2020 | 127 | 0.040 |
Why?
|
| Genes, Bacterial | 1 | 2020 | 198 | 0.040 |
Why?
|
| Male | 2 | 2021 | 42657 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2020 | 261 | 0.040 |
Why?
|
| Machine Learning | 1 | 2021 | 270 | 0.040 |
Why?
|
| RAW 264.7 Cells | 1 | 2017 | 18 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2022 | 689 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 1576 | 0.040 |
Why?
|
| Fluorescent Dyes | 1 | 2017 | 245 | 0.030 |
Why?
|
| Lung | 1 | 2022 | 1292 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1864 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 2018 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 1859 | 0.030 |
Why?
|
| Chemokine CXCL12 | 1 | 2015 | 38 | 0.030 |
Why?
|
| Receptors, CXCR4 | 1 | 2015 | 45 | 0.030 |
Why?
|
| Female | 3 | 2024 | 46571 | 0.030 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2013 | 15 | 0.030 |
Why?
|
| I-kappa B Proteins | 1 | 2013 | 54 | 0.030 |
Why?
|
| Interleukin-1 | 1 | 2013 | 72 | 0.030 |
Why?
|
| Cysteine Endopeptidases | 1 | 2013 | 87 | 0.030 |
Why?
|
| Biomarkers | 1 | 2020 | 1775 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2013 | 173 | 0.030 |
Why?
|
| Prognosis | 1 | 2020 | 3796 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2013 | 696 | 0.030 |
Why?
|
| Asthma | 1 | 2020 | 984 | 0.020 |
Why?
|
| Risk Factors | 1 | 2021 | 5554 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2013 | 1244 | 0.020 |
Why?
|
| Apoptosis | 1 | 2013 | 1718 | 0.020 |
Why?
|
| Middle Aged | 1 | 2021 | 26132 | 0.010 |
Why?
|
| Adult | 1 | 2021 | 26810 | 0.010 |
Why?
|